Latest News on PACS

Financial News Based On Company


Advertisement
Advertisement

PACS: Raised 2026 EBITDA outlook and 78 new facilities underpin continued growth

https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:4707583:0-pacs-raised-2026-ebitda-outlook-and-78-new-facilities-underpin-continued-growth/
PACS Group, Inc. has raised its 2026 EBITDA guidance midpoint to $690 million from an initial $565 million, supported by the addition of 78 new facilities. The company anticipates mid-single-digit same-store growth and double-digit overall growth for 2027, driven by facility ramp-ups and a focus on quality operations. This positive outlook is based on their recent Stephens Annual Investment Conference.

PACS Group, Inc. to Present at the Stephens Annual Investment Conference on November 19, 2026

https://www.businesswire.com/news/home/20261116005817/en/PACS-Group-Inc.-to-Present-at-the-Stephens-Annual-Investment-Conference-on-November-19-2026
PACS Group, Inc. (NYSE: PACS) announced that its CEO, CFO, and COO will present at the Stephens Annual Investment Conference on November 19, 2026, in Nashville, TN. They will discuss the company's operations and growth strategy, with a live webcast of the presentation available at 10:15 a.m. CT. The webcast will also be archived for 90 days, and the latest investor presentation is accessible online.

Form 144 PACS Group For: 15 November By Investing.com

https://ng.investing.com/news/stock-market-news/form-144-pacs-group-for-15-november-93CH-2808856
This article from Investing.com announces the filing of Form 144 for PACS Group, pertaining to transactions on November 15. The brief report indicates the company's stock symbol is PACS, which showed a 0.67% increase. The article provides only this minimal information regarding the Form 144 filing.

Form 144 PACS Group For: 15 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-144-pacs-group-for-15-november-93CH-4959555
This article from Investing.com announces the filing of Form 144 for PACS Group on November 15, 2026. Form 144 is a notice of the intent to sell restricted securities. The brief article provides no further details beyond the date and the entity involved.

PACS Group president & COO Joshua Jergensen sells $2.00 million in stock

https://uk.investing.com/news/stock-market-news/pacs-group-president--coo-joshua-jergensen-sells-200-million-in-stock-93CH-4979269
Joshua Jergensen, President and COO of PACS Group, Inc. (NASDAQ:PACS), sold 39,000 shares of the company's common stock for approximately $2.00 million on November 11, 2026. These sales were executed under a Rule 10b5-1 trading plan and occurred while PACS shares were trading near their 52-week high, having delivered a 319% return over the past year.
Advertisement

PACS Group president & COO Joshua Jergensen sells $2.00 million in stock

https://www.investing.com/news/insider-trading-news/pacs-group-president--coo-joshua-jergensen-sells-200-million-in-stock-93CH-5023712
Joshua Jergensen, President and COO of PACS Group, Inc., sold 39,000 shares of company stock for approximately $2.00 million on November 11, 2026. These sales were executed through a Rule 10b5-1 trading plan as PACS shares traded near their 52-week high, following a significant 319% return over the past year. Despite recent sales, Jergensen still directly holds over 2.4 million shares.

Law firm investigates PACS Group officers for possible shareholder rights breaches

https://pluang.com/en/news-feed/penyelidikan-pelanggaran-tugas-fidusia-insider-pacs-group
Halper Sadeh LLC is investigating whether officers and directors of PACS Group, Inc. breached their fiduciary duties to shareholders. The investigation aims to protect investor interests and potentially lead to corporate reforms or financial awards for long-term PACS stockholders. The firm offers free consultations and works on a contingent fee basis, urging shareholders to act promptly.

PACS Group, Inc. (PACS) Seasonal returns chart

https://au.finance.yahoo.com/quote/PACS/seasonality/
The article provides a seasonal returns chart for PACS Group, Inc. (PACS) on Yahoo Finance, displaying average monthly price returns from 2024 to 2026. It includes current stock information, showing PACS at $48.32, up 0.67% at close on November 13. The page also features navigation to various financial data sections like news, charts, statistics, and historical data.

Fifty-Eight PACS Post-Acute Locations Named Top Nursing Homes for 2027 by U.S. News & World Report

https://www.businesswire.com/news/home/20261110874189/en/Fifty-Eight-PACS-Post-Acute-Locations-Named-Top-Nursing-Homes-for-2027-by-U.S.-News-World-Report
PACS Group, Inc. announced that 58 of its post-acute care communities have been recognized by U.S. News & World Report on its "Best Nursing Homes for 2027" list. This recognition highlights the company's commitment to patient care and quality outcomes, with evaluations based on 17 quality measures. PACS Group operates 398 post-acute care facilities across 22 states, serving over 38,000 patients daily.

We Think PACS Group's (NYSE:PACS) Robust Earnings Are Conservative

https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/we-think-pacs-groups-nysepacs-robust-earnings-are-conservati
PACS Group's recent strong earnings are considered conservative due to its negative accrual ratio, indicating that its free cash flow significantly exceeded its reported statutory profit. This suggests the company's true earnings potential might be understated, a positive sign for shareholders, especially given its growing EPS. The article emphasizes that this analysis focuses on one data point and encourages further research into other financial factors and risks.
Advertisement

Form 4 PACS Group, Inc. For: Nov 05 Filed by: Murray Jason Hulse

https://www.streetinsider.com/SEC+Filings/Form+4+PACS+Group%2C+Inc.+For%3A+Nov+05+Filed+by%3A+Murray+Jason+Hulse/27316660.html
This article details a Form 4 filing for PACS Group, Inc., showing insider transactions by Murray Jason Hulse, Co-Founder, CEO & Chairman. The filing indicates sales of common stock on November 5, 2026, totaling 19,235 shares at weighted average prices of $50.6016 and $51.101 per share. These transactions were executed under a Rule 10b5-1 trading plan adopted in May 2026.

‘This is what we do,’ PACS leaders say, touting buying spree, 90 percent occupancy

https://www.mcknights.com/news/this-is-what-we-do-pacs-leaders-say-touting-buying-spree-90-percent-occupancy/
PACS Group, the nation's second-largest skilled nursing operator, has significantly expanded its portfolio by adding 43 facilities since Q3, including 10 nursing homes and one assisted living facility in Texas. The company reported overall occupancy of 90.2%, with a higher 91.3% at facilities owned since early 2025, demonstrating strong growth despite new acquisitions often starting with lower occupancy. Executives credit their operating model and focus on clinical execution for turning around underperforming facilities, citing a Tennessee facility that exited the Special Focus Facilities program under PACS leadership.

Form 144 PACS Group, Inc. Filed by: Hancock Mark

https://www.streetinsider.com/SEC+Filings/Form+144+PACS+Group%2C+Inc.+Filed+by%3A+Hancock+Mark/27292085.html
Mark Hancock has filed a Form 144 for PACS Group, Inc., indicating a proposed sale of 186,696 shares of common stock with an aggregate market value of $9,418,383.80. The securities were acquired on March 1, 2023, during the issuer's formation. Hancock has also reported previous sales of PACS Group common stock in September and October 2026.

PACS Group Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/62877765/pacs-group-q3-2026-earnings-call-transcript
PACS Group reported robust Q3 2026 results, with an 11.5% year-over-year revenue increase to $1.5 billion and net income growth of 16.2% to $60.8 million, driven by strong same-store performance and strategic acquisitions. The company successfully integrated 31 newly acquired facilities and expanded into Florida and Texas, while also raising its full-year 2026 revenue guidance to $5.95 billion-$6.05 billion and adjusted EBITDA guidance to $685 million-$695 million. PACS Group emphasized its disciplined growth strategy, commitment to high-quality care, and confidence in managing ongoing government investigations, all supported by significant cash generation and financial flexibility.

PACS Group Inc stock hits all-time high of 50.41 USD

https://www.investing.com/news/company-news/pacs-group-inc-stock-hits-alltime-high-of-5041-usd-93CH-5000577
PACS Group Inc (PACS) stock has reached an all-time high of $50.41, reflecting a 287.23% increase over the past year and a 44% return in the last six months. The company has a market capitalization of $7.4 billion and is expanding, having entered into agreements to acquire 32 skilled nursing facilities in Florida and completed further closings of its Eduro Healthcare transaction. Truist Securities maintains a Buy rating with a $62.00 price target.
Advertisement

PACS Group Q3 2026 Earnings Call Is Live

https://www.tradingview.com/news/urn:live_audio:quartr.com:724386:0-pacs-group-q3-2026-earnings-call-is-live/
PACS Group's Q3 2026 earnings call has just started, where executives will discuss the latest financial results and answer questions from analysts. This event is crucial for investors following PACS, as management commentary on future demand, margins, or capital spending can significantly impact market sentiment. The article emphasizes that such calls can move markets as much as the earnings release itself.

PACS Group (PACS) Stock Price, News & Analysis

https://247wallst.com/companies/pacs/
PACS Group, Inc. is a holding company that invests in post-acute healthcare facilities and services, operating 398 facilities across 21 states. The company recently reported strong Q3 2026 earnings, with EPS and revenue exceeding estimates, and adjusted EBITDA climbing 33.6%. Management raised full-year EBITDA guidance and expanded its operations into Florida and Texas.

PACS Group raises FY26 sales guidance to $5.950B-$6.050B

https://scanx.trade/stock-market-news/companies/pacs-group-raises-fy26-sales-guidance-5-950b-6-050b/55297022
PACS Group has raised its fiscal year 2026 sales guidance to between $5.950 billion and $6.050 billion, exceeding its previous projection of $5.750 billion-$5.850 billion and the analyst estimate of $5.851 billion. This upward revision reflects strong confidence in revenue conversion, with the new lowest expected revenue figure surpassing the prior highest estimate.

PACS Group surges 6% on earnings beat, raised guidance

https://www.investing.com/news/earnings/pacs-group-surges-6-on-earnings-beat-raised-guidance-4996854
PACS Group, Inc. (NYSE: PACS) reported strong third-quarter results, with adjusted earnings per share exceeding analyst estimates and revenue increasing 11.5% year-over-year. The post-acute healthcare company raised its full-year 2026 adjusted EBITDA and revenue guidance, citing robust operational performance and significant growth in same-store skilled nursing facility revenue and occupancy. Shares rose 6% in after-hours trading following the positive report.

PACS: Q3 growth and acquisitions underpin higher FY 2026 revenue and Adjusted EBITDA guidance

https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:4270548:0-pacs-q3-growth-and-acquisitions-underpin-higher-fy-2026-revenue-and-adjusted-ebitda-guidance/
PACS Group, Inc. (PACS) reported an 11.5% increase in Q3 revenue and a 33.6% rise in Adjusted EBITDA year-over-year, achieving an Adjusted EPS of $0.63. The company has revised its FY 2026 guidance upwards, incorporating newly acquired operations in Florida and Texas, as it continues to drive growth through acquisitions and operational improvements.
Advertisement

PACS Group, Inc. (PACS) Misses Q3 EPS by 28c

https://www.streetinsider.com/Earnings/PACS+Group%2C+Inc.+%28PACS%29+Misses+Q3+EPS+by+28c/27282491.html
PACS Group, Inc. (NYSE: PACS) reported its Q3 earnings per share (EPS) of $0.27, falling short of the analyst estimate of $0.55 by $0.28. The company's revenue for the quarter was $340.55 million. The stock is currently trading at $46.68, up 2.41% today.

Q3 profit rises at PACS Group (PACS). It adds 43 facilities via long-term leases after quarter-end.

https://www.stocktitan.net/sec-filings/PACS/10-q-pacs-group-inc-quarterly-earnings-report-1ee5a4c0ee95.html
PACS Group reported a significant increase in third-quarter net income to $60.8 million, up from $52.4 million in the prior year, with diluted earnings per share rising to $0.37 from $0.32. The company's revenue also grew to $1,498.578 million. After the quarter ended, PACS Group expanded its operations by adding 43 stand-alone facilities through long-term leases, which increased its skilled nursing and assisted living bed count.

PACS Group, Inc. Reports Third Quarter 2026 Results

https://www.businesswire.com/news/home/20261103453220/en/PACS-Group-Inc.-Reports-Third-Quarter-2026-Results
PACS Group, Inc. announced strong financial results for the third quarter of 2026, with revenue increasing 11.5% year-over-year to $1.50 billion and Adjusted EBITDA growing 33.6% to $175.7 million. The company also raised its full-year 2026 Adjusted EBITDA guidance to $685 million to $695 million and revenue guidance to $5.95 billion to $6.05 billion, driven by continued operational improvements and strategic acquisitions in Florida and Texas. Occupancy rates and skilled patient mix also saw significant improvements across its skilled nursing facilities.

PACS Q3'26 Earnings: EPS estimate is 0.58 USD

https://www.tradingview.com/news/tradingview:e3288a80aeb17:0-pacs-q3-26-earnings-eps-estimate-is-0-58-usd/
PACS Group, Inc. (PACS) is scheduled to release its Q3'26 earnings after market close on November 3, 2026, with an expected disclosure time of 4:00 PM ET (9:00 PM UTC). Analysts estimate revenue for Q3'26 to be $1.46 billion and earnings per share (EPS) to be $0.58. The article also provides historical reported and estimated revenue and EPS figures, along with surprise percentages.

Form 4 PACS Group Inc: Michelle Renee Lewis (Chief Accounting Officer) For: 28 October

https://uk.investing.com/news/stock-market-news/form-4-pacs-group-inc-michelle-renee-lewis-chief-accounting-officer-for-28-october-93CH-4946832
This article reports on a Form 4 filing for PACS Group Inc, indicating a transaction by Michelle Renee Lewis, the Chief Accounting Officer, on October 28th. The filing details insider trading activity for the company.
Advertisement

PACS Group chief accounting officer sells $592,647 in shares

https://www.investing.com/news/insider-trading-news/pacs-group-chief-accounting-officer-sells-592647-in-shares-93CH-4988923
Michelle Renee Lewis, Chief Accounting Officer at PACS Group, Inc. (NASDAQ:PACS), sold 11,828 shares of common stock for a total of $592,647 in late October. The transactions were carried out pursuant to a Rule 10b5-1 trading plan and occurred as PACS stock traded near its 52-week high after a 291% gain over the past year. Despite the stock appearing overvalued according to InvestingPro, the company recently announced expansion plans and leadership changes, with Truist Securities reiterating a Buy rating.

Mark Hancock proposes selling 4,280 PACS Group (NYSE: PACS) shares through Citigroup.

https://www.stocktitan.net/sec-filings/PACS/144-pacs-group-inc-sec-filing-062c0380d4bc.html
Mark Hancock, an officer, director, and 10% stockholder of PACS Group, Inc., has proposed selling 4,280 common shares valued at $214,101.01 through Citigroup Global Markets Inc. The approximate sale date is October 29, 2026. This proposed sale follows several other reported sales by Hancock in the past three months, including significant transactions in September and October 2026.

A proposed sale covers 9,024 PACS Group (PACS) shares through Citigroup Global Markets.

https://www.stocktitan.net/sec-filings/PACS/144-pacs-group-inc-sec-filing-2c3cb68d65e0.html
Mark Hancock of PACS Group, Inc. has filed a Form 144 notice proposing to sell 9,024 common shares through Citigroup Global Markets Inc., valued at approximately $452,120.45, with an approximate sale date of October 28, 2026. The notice also details prior sales by Hancock of 144,318 shares on September 14, 2026, and 155,682 shares on September 15, 2026. This proposed sale is part of an ongoing process for insiders to legally resell restricted shares to the public under Rule 144 regulations.

Officer Michelle Renee Lewis proposes selling 15,000 shares of PACS Group (PACS).

https://www.stocktitan.net/sec-filings/PACS/144-pacs-group-inc-sec-filing-903881a32870.html
Michelle Renee Lewis, an officer at PACS Group, Inc., has filed a Rule 144 notice proposing to sell 15,000 common shares with an aggregate market value of $717,750 through J.P. Morgan Securities LLC. These shares were acquired via RSU vesting on April 15, 2026. The proposed sale is expected on October 28, 2026, or within three months of the notice date.

Don't Ignore The Insider Selling In PACS Group

https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/dont-ignore-the-insider-selling-in-pacs-group
Recent insider selling at PACS Group (NYSE:PACS) raises concerns, particularly a substantial sale by Co-Founder Jason Murray and a larger sale by insider John Mitchell below the current share price. While the company still has high insider ownership (69%), the pattern of selling over the last year, with no insider buying in the past three months, suggests caution despite the company's growing earnings.
Advertisement

PACS stock hits all-time high at 49.56 USD

https://www.investing.com/news/company-news/pacs-stock-hits-alltime-high-at-4956-usd-93CH-4973211
PACS Group Inc. stock has reached an all-time high of 49.56 USD, marking a 291.59% increase over the past year and valuing the company at $7.5 billion. This growth is supported by 15% revenue growth and forecasted earnings of $2.53 per share for 2026. Despite trading above its fair value, the company continues its strategic expansion, including acquiring 32 skilled nursing facilities in Florida and appointing a new Chief Legal Officer.

How Pacs Group Inc. (PACS) Affects Rotational Strategy Timing

https://news.stocktradersdaily.com/news_release/40/How_Pacs_Group_Inc._PACS_Affects_Rotational_Strategy_Timing_102726014401_1793079841.html
Pacs Group Inc. (NASDAQ: PACS) exhibits strong sentiment across all time horizons, supporting an overweight bias according to AI models. The analysis identifies a 51.5:1 risk-reward setup, targeting a 14.3% gain against a 0.3% risk. Three distinct institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—are outlined with specific entry, target, and stop-loss zones.

PACS group CEO Jason Murray sells $4 million in company stock

https://www.investing.com/news/insider-trading-news/pacs-group-ceo-jason-murray-sells-4-million-in-company-stock-93CH-4973890
Jason Murray, CEO of PACS Group Inc., sold over $4 million worth of common stock in late October 2026 through a pre-arranged trading plan. These sales occurred while PACS stock was trading near its 52-week high after a significant 285% return over the past year, with InvestingPro analysis suggesting the stock is currently overvalued despite strong financial health and positive analyst targets. The company also recently expanded into Florida with 32 skilled nursing facility acquisitions and appointed a new Chief Legal Officer.

Form 4 PACS Group Inc: Jason Hulse Murray (Director, 10% Owner, Co-Founder, CEO & Chairman) For: 22 October

https://ng.investing.com/news/stock-market-news/form-4-pacs-group-inc-jason-hulse-murray-director-10-owner-cofounder-ceo--chairman-for-22-october-93CH-2758506
This article reports on a Form 4 filing for PACS Group Inc, detailing insider transaction information for Jason Hulse Murray, who holds multiple executive and ownership roles including Director, 10% Owner, Co-Founder, CEO, and Chairman. The filing pertains to activities on October 22. The brief article, published by Investing.com, indicates a +2.35% movement for PACS stock.

PACS group CEO Jason Murray sells $4 million in company stock

https://uk.investing.com/news/stock-market-news/pacs-group-ceo-jason-murray-sells-4-million-in-company-stock-93CH-4932679
Jason Murray, CEO of PACS Group Inc., sold over $4 million worth of company stock in late October 2026 through pre-arranged trading plans. These sales occurred while PACS stock was trading near its 52-week high, following a significant 285% return over the past year. Despite the sales, Murray still holds a substantial number of shares, and the company has been expanding its operations, including acquiring 32 skilled nursing facilities in Florida.
Advertisement

PACS stock hits all-time high at 49.56 USD By Investing.com

https://uk.investing.com/news/stock-market-news/pacs-stock-hits-alltime-high-at-4956-usd-93CH-4932070
PACS Group Inc. (PACS) stock reached an all-time high of $49.56, marking a 291.59% surge over the past year and valuing the company at $7.5 billion. Despite this strong performance, InvestingPro analysis indicates the stock is currently overvalued. The company recently expanded significantly by acquiring 32 skilled nursing facilities in Florida and appointed Patrick J. Murphy as its new Chief Legal Officer.

PACS Group, Inc. Estimates – NYSE:PACS

https://www.tradingview.com/symbols/NYSE-PACS/financials-estimates/
This article from TradingView provides an overview of PACS Group, Inc. (NYSE: PACS) financial data, focusing on reported actuals and analyst estimates. Users can explore income statement, balance sheet, cash flow, and valuation metrics, comparing actual results with average, high, and low estimates. The platform also visualizes financial trends over time for the hospital/nursing management company.

PACS Group, Inc. (PACS) stock price, news, quote and history

https://sg.finance.yahoo.com/quote/PACS/
This article provides a comprehensive overview of PACS Group, Inc. (PACS) stock, including its current price, market data, and historical performance. It details the company's financials, analyst ratings, and an overview of its operations in the medical care facilities sector. The stock closed at $47.64 with a slight gain, and has shown significant year-to-date and 1-year returns.

Form 4 PACS Group Inc: Jason Hulse Murray (Director, 10% Owner, Co-Founder, CEO & Chairman) For: 19 October

https://ng.investing.com/news/stock-market-news/form-4-pacs-group-inc-jason-hulse-murray-director-10-owner-cofounder-ceo--chairman-for-19-october-93CH-2749844
This article reports on a Form 4 filing for PACS Group Inc., detailing an insider transaction by Jason Hulse Murray, who holds multiple executive and ownership roles including Director, 10% Owner, Co-Founder, CEO, and Chairman. The transaction date specified in the filing is October 19.

PACS Group CEO Jason Murray sells $2.18m in company stock

https://www.investing.com/news/insider-trading-news/pacs-group-ceo-jason-murray-sells-218m-in-company-stock-93CH-4964355
Jason Murray, Co-Founder, CEO, and Chairman of PACS Group, Inc. (NASDAQ:PACS), recently sold over $2.18 million in company stock through three separate transactions between October 19 and October 21, 2026. These sales were executed under a Rule 10b5-1 trading plan and occurred while PACS stock was trading near its 52-week high. Following these sales, Murray directly holds over 54 million shares, and the company is actively expanding with new acquisitions and leadership appointments.
Advertisement

Pacs Group Insider Sold Shares Worth $5,614,667, According to a Recent SEC Filing

https://finance.yahoo.com/markets/stocks/articles/pacs-group-insider-sold-shares-080513925.html
Jason Hulse Murray, a 10% owner, director, co-founder, CEO, and Chairman of Pacs Group, sold shares worth $5,614,667. This transaction was disclosed in a recent SEC filing. The full details of the article require a premium subscription.

Form 4 PACS Group Inc: Joshua Jergensen (President & COO) For: 14 October By Investing.com

https://za.investing.com/news/stock-market-news/form-4-pacs-group-inc-joshua-jergensen-president--coo-for-14-october-93CH-4509434
This article reports on a Form 4 filing for PACS Group Inc, indicating activity by Joshua Jergensen, the company's President & COO, related to October 14. The filing was published on October 17, 2026, and is accompanied by a PACS stock quote showing a -1.76% change.

PACS - PACS Group, Inc | News

https://www.otcmarkets.com/stock/PACS/news/PACS-Group-Announces-Chief-Legal-Officer-Transition?e&id=3540758
This article provides a brief description of OTC Markets, specifically mentioning that it is the official site for OTCQX, OTCQB, OTCID, and Pink Limited Markets. It appears to be a general information page about the OTC Markets rather than a news article about PACS Group, Inc.

PACS Group CEO Hulse sells $5.6m in PACS stock

https://www.investing.com/news/insider-trading-news/pacs-group-ceo-hulse-sells-56m-in-pacs-stock-93CH-4954932
Jason Hulse, CEO of PACS Group Inc. (NASDAQ:PACS), sold approximately $5.6 million worth of company stock between October 14 and October 16, 2026, across 118,729 shares. The sales were conducted via a Rule 10b5-1 trading plan and occurred as PACS stock nears its 52-week high after a 277% return over the past year. InvestingPro analysis suggests the stock is currently overvalued, despite recent strategic expansions including new facility acquisitions and leadership changes.

Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 18.52 Million in Common Stocks

https://www.moomoo.com/news/flash/1001478235/form-144-pacs-group-pacsus-officer-proposes-to-sell-18
An officer of PACS Group (PACS.US) has filed a Form 144, indicating a proposal to sell common stocks valued at $18.52 million. This filing suggests an upcoming transaction by an insider at the company.
Advertisement

PACS Group president & COO Joshua Jergensen sells $1.78M in stock

https://www.investing.com/news/insider-trading-news/pacs-group-president--coo-joshua-jergensen-sells-178m-in-stock-93CH-4954934
Joshua Jergensen, President & COO of PACS Group Inc., sold $1.78 million worth of company stock on October 14, 2026, as part of a pre-arranged trading plan. This insider sale comes as PACS stock is near its 52-week high, with InvestingPro analysis suggesting the stock may be overvalued. The company recently announced significant expansion through the acquisition of 32 skilled nursing facilities in Florida and appointed a new Chief Legal Officer.

A proposed sale of 386,667 shares follows Jason Murray’s earlier sales at PACS Group (PACS).

https://www.stocktitan.net/sec-filings/PACS/144-pacs-group-inc-sec-filing-e7ff65f9468b.html
Jason Murray, associated with PACS Group, has filed a Rule 144 notice proposing to sell 386,667 common shares through UBS Financial Services, Inc., valued at approximately $18.5 million, with an approximate sale date of October 16, 2026. This proposed sale follows a series of common stock sales by Murray between August 17 and October 16, 2026. The filing indicates 158,335,612 common shares outstanding for PACS Group.

PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?

https://finance.yahoo.com/markets/stocks/articles/pacs-group-inc-pacs-surges-105200840.html
PACS Group, Inc. (PACS) shares rose 6.2% on increased volume, reflecting investor optimism ahead of its Q3 2026 financial results. The company is projected to report an 8.1% revenue growth and 75% earnings growth, with an estimated EPS of $0.56. While strong growth expectations are positive, the Zacks Consensus Estimate for EPS has remained unchanged, suggesting that continued gains may depend on future earnings estimate revisions.

Form 144 PACS Group For: 15 October By Investing.com

https://ng.investing.com/news/stock-market-news/form-144-pacs-group-for-15-october-93CH-2737667
This article from Investing.com is a regulatory filing notification, specifically a Form 144 for PACS Group, published on October 15, 2026. It briefly mentions the company and its stock performance. The article primarily serves as a news alert for financial market participants regarding this filing.

Form 144 PACS Group For: 15 October By Investing.com

https://ca.investing.com/news/stock-market-news/form-144-pacs-group-for-15-october-93CH-4882208
This article from Investing.com announces the filing of Form 144 for PACS Group on October 15th. It is a brief, factual update indicating a financial disclosure for the company. The article contains minimal textual content beyond the headline and date.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement